Free Trial
OTCMKTS:MSLP

MusclePharm (MSLP) Stock Price, News & Analysis

MusclePharm logo

About MusclePharm Stock (OTCMKTS:MSLP)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
26,442 shs
Market Capitalization
$7 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MSLP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MusclePharm and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MSLP Stock News Headlines

Why Trump’s “Smart Dollar” could rewrite the rules
MUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's latest plans for the dollar – and they're so bold that one central bank chair says we haven't seen anything like it in almost a century. Our Wall Street insider says it's the start of a once-in-a-lifetime investing opportunity, IF you act now.tc pixel
The 5 best muscle rubs of 2024
See More Headlines

MSLP Stock Analysis - Frequently Asked Questions

MusclePharm Co. (OTCMKTS:MSLP) issued its earnings results on Monday, August, 10th. The company reported ($0.51) EPS for the quarter, missing the consensus estimate of ($0.19) by $0.32. The firm had revenue of $50.48 million for the quarter, compared to the consensus estimate of $55 million.

Shares of MSLP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MusclePharm investors own include Altimmune (ALT), Avino Silver & Gold Mines (ASM), BellRing Brands (BRBR), Dalradian Resources (DALR), EVRAZ (EVRZF), Humacyte (HUMA) and Rent-A-Center (RCII).

Company Calendar

Last Earnings
8/10/2015
Today
9/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:MSLP
CIK
1415684
Fax
N/A
Employees
20
Year Founded
2008

Profitability

EPS (Trailing Twelve Months)
($0.58)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$12.87 million
Net Margins
-38.51%
Pretax Margin
-38.52%
Return on Equity
N/A
Return on Assets
-169.56%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.25
Quick Ratio
0.23

Sales & Book Value

Annual Sales
$50.04 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.94) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
33,390,000
Free Float
13,121,000
Market Cap
$7 thousand
Optionable
Not Optionable
Beta
-0.07

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (OTCMKTS:MSLP) was last updated on 9/15/2025 by MarketBeat.com Staff
From Our Partners